View Older Stories View More Recent Stories
-
BioAtla Inc. (BCAB) PT Lowered to $1 at Citizens JMP
-
Citizens JMP Reiterates Market Outperform Rating on Arbutus Biopharma (ABUS)
-
Analysis-For China and US Inc, Trump's trade war feels much worse this time
-
WHO proposing to cut jobs and slash budget by a fifth, memo shows
-
Irish charity GOAL to cut 30% of staff due to global aid cuts
-
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
-
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress
-
Remaining USAID staff fired, Trump says Myanmar will still get earthquake aid
-
Oportun: 5 Financial Tips for New Parents
-
Getty Images (GETY) Announced as the Official Photography Partner of Major League Soccer
-
LiqTech International Announces Financial Results for Fourth Quarter and Full Year 2024
-
Analysis-Deal slump hits US high-grade bond supply, pressures spreads
-
German unemployment rises amid economic slowdown
-
US car buyers face higher prices, less choice under Trump's tariffs
-
Italian top government official seen joining STMicroelectronics supervisory board
-
Trading Day: Investors find auto motive for caution
-
P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results
-
Heliogen, Inc. Announces Fourth Quarter and Full Year 2024 Financial and Operational Results
-
BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
-
Tesla stock gains as it is seen as 'winner' from Trump's auto tariffs
-
Three Intel board members to retire in latest shakeup amid turnaround
-
Ferrari raises some prices in response to U.S auto tariffs
-
Kennedy to slash 10,000 jobs in major overhaul of US health agencies
-
Nkarta Inc. (NKTX) PT Lowered to $14 at Stifel
-
Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
-
Exclusive-FDA staff struggle to meet product review deadlines after DOGE layoffs
-
H.C. Wainwright Reiterates Buy Rating on Nkarta Inc. (NKTX)
-
Nkarta Inc. (NKTX) PT Lowered to $14 at Stifel
-
US auto tariffs shake global industry as higher prices, job losses loom
-
ALERT: US is Already in Recession - Michael Eisenga, CEO of First American Properties
-
Jefferies profit misses estimates as bond trading, equity underwriting weaken
-
Steelcase Reports Fourth Quarter and Fiscal 2025 Results
-
Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates
-
MillerKnoll, Inc. Reports Third Quarter Fiscal 2025 Results
-
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
-
Inventiva reports its 2024 full year results and provides a business update
-
X to report first annual ad revenue growth since Musk's takeover, data shows
-
Trump uses 2019 national security probe to justify tariffs on auto imports
-
Canada will respond to Trump auto tariffs with its own trade actions
-
BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market
-
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
-
Adaptimmune Therapeutics plc (ADAP) PT Lowered to $1.75 at Guggenheim
-
Canada steel, aluminum plants lay off workers due to US tariffs
-
Analysis-Wall Street job cuts loom as market turmoil stalls deals
-
BRP PRESENTS ITS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
-
Archer Daniels Midland (ADM) Cuts Jobs in Grain Trading Division - Reuters
-
Exclusive-ADM cuts jobs in grain trading division, sources say
-
ADM CEO's 2024 compensation dips amid accounting issues, job cuts
-
Compass Minerals (CMP) to eliminate over 10% of the company’s corporate workforce
-
Compass Minerals Announces Cost Structure Reductions to Align With Current Business Needs
